Swiss pharmaceutical giant Novartis announced a series of multibillion-dollar deals with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.
Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer...
Questions of affordability, eligibility, immigrant access and the response from employers and...
IDT uses Microsoft Dynamics AX ERP software, implemented by Edgewater Fullscope, to support new products and market expansion, as well as address traceability requirements. IDT processes over 25,000 products per day and has over 86,000 customers around the world.
The judge issued a preliminary injunction Tuesday after pharmaceutical company, Zogenix, argued in a lawsuit that the ban issued by Gov. Deval Patrick in March is unconstitutional.
Total U.S. prescription drug spending climbed more than 3 percent last year, propelled in part by fewer patent expirations that would have allowed for cheaper generic alternatives, according to the data firm IMS Health.
The company said in a statement that it has no knowledge of any ongoing investigation by the DOJ or the FBI. It also said that it has not received any request for information from either agency.
The British drug company faces corruption probes in China and Iraq. It said in a statement it is cooperating with investigators and that one employee had been disciplined in 2011 for inappropriate actions.
Gov. Deval Patrick defended the state's first-in-the-nation ban of the powerful new painkiller Zohydro after a federal judge suggested in court that his administration may have overreached.
Teva Pharmaceutical Industries said Tuesday it is now selling a generic version of the heart medication Lovaza, which is used to treat high triglyceride levels.
Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business.
The maker of Zohydro, a controversial new prescription painkiller, has filed a lawsuit in federal court seeking to block Massachusetts' ban on local doctors prescribing and dispensing the drug.
A U.S. jury ordered Takeda Pharmaceutical Co. and Eli Lilly to pay $9 billion in punitive damages over a diabetes medicine linked to cancer.
GlaxoSmithKline said Monday it has launched an investigation into allegations it bribed doctors in Iraq, as the pharmaceuticals giant remains embroiled in a major corruption scandal in China.
India's Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4 billion deal, the companies said Monday.
The backlash against Zohydro has been growing since last year, when the FDA approved the drug against the recommendation of an internal advisory committee.
Texas prison officials have offered scant evidence to support their claim that pharmacies that supply the state with execution drugs would be in danger of violence if their identities were made public.
Drug maker Actavis Plc plans to expand its reach into Southeast Asia by spending about $100 million to buy Silom Medical Co., a generic pharmaceutical company focused on Thailand.
GlaxoSmithKline is recalling the weight loss drug Alli after receiving reports of unknown pills and tablets in the bottles.
After months of criticism over its recently launched painkiller Zohydro, the maker of the powerful narcotic is highlighting an unusual oversight board that it's assembled to try and prevent abuse of the drug.
Twenty-five pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat, the Food and Drug Administration said Wednesday.
The Arkansas Supreme Court on Thursday overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drug maker's marketing of the antipsychotic drug Risperdal.
Hawaii's attorney general is suing the makers of a widely prescribed blood thinner that he says a significant portion of the state's population has difficulty metabolizing.
Horizon Pharma plans to buy Vidara Therapeutics International in a cash-and-stock deal that will add the immune system disorder drug Actimmune to the specialty drug maker's product portfolio.
The pills are so packed with nutrients that you'd have to eat a gazillion candy bars to get the amount being tested in this study, which will enroll 18,000 men and women nationwide.
The head of the Food and Drug Administration says the much-debated painkiller Zohydro fills an "important and unique niche" for treating pain.
Purdue Pharma says it has completed testing of an abuse-resistant version of the painkiller hydrocodone, a surprise development that could derail sales of the recently launched Zohydro.
A drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care experts, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences.
- Page 1